Pharma Monopoly: The Battle for the Future of Medicines
暫譯: 藥品壟斷：未來醫藥的戰鬥
Amin, Tahir, Malpani, Rohit
- 出版商: Polity
- 出版日期: 2026-05-26
- 售價: $1,380
- 貴賓價: 9.8 折 $1,352
- 語言: 英文
- 頁數: 256
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 1509558322
- ISBN-13: 9781509558322
-
相關分類:
投資理財 Investment
尚未上市，無法訂購
商品描述
Tahir Amin and Rohit Malpani, two leading figures in the movement for access to medicines, examine the origins of this system of rules that champions monopolies and the false god of innovation over the public interest and human well-being. They tell the story of how, move by move, governments have ceded control and then empowered pharmaceutical companies, making it increasingly hard to undo the damages wreaked along the way. From their unique vantage points and experiences, they critique global health initiatives and philanthropists for maintaining the status quo and warn of a future dominated by financial markets and artificial intelligence that will reinforce the worst practices of yesterday and portends new injustices for everyone.
Ultimately, their book questions the foundations of international efforts to improve access to medicines and calls for a new way forward that can rekindle a movement for justice.
商品描述(中文翻譯)
毫無疑問，全球有數百萬人缺乏隨時獲取救命藥物的自由。數十年來，人們一直在為糾正這一問題而奮鬥，然而，正如新冠疫情令人痛心地顯示的那樣，廣大人類仍然無法獲得這些藥物。原因在於，數十億人因過時的專利規則和以新自由主義為主導的經濟政策而被積極剝奪了獲得可負擔藥物的權利。這並非偶然，也不僅僅是製藥行業的問題。
塔希爾·阿敏（Tahir Amin）和羅希特·馬爾帕尼（Rohit Malpani）是推動藥物獲取運動的兩位領軍人物，他們探討了這一體系的起源，該體系推崇壟斷和虛假的創新神明，卻忽視了公共利益和人類福祉。他們講述了政府如何一步步放棄控制，然後賦予製藥公司權力，讓人們越來越難以修復沿途造成的損害。從他們獨特的視角和經驗出發，他們批評全球健康倡議和慈善家維持現狀，並警告未來將由金融市場和人工智慧主導，這將加強過去的最壞做法，並預示著對每個人的新不公。
最終，他們的書質疑國際改善藥物獲取的努力基礎，並呼籲一種新的前進方式，以重新點燃追求正義的運動。
作者簡介
Tahir Amin is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK). He has also served as advisor/consultant to international groups including the European Patent Office, the World Health Organization, and Unitaid, and has testified before the US Congress on patents and unsustainable drug prices.
Rohit Malpani is an independent consultant and former Director of Policy for the Médecins Sans Frontières Access Campaign. He has previously served as a Board Member of Unitaid, Special Advisor at Oxfam, and a Human Rights Advisor at the World Health Organization.
作者簡介(中文翻譯)
Tahir Amin 是藥物、可及性與知識倡議（Initiative for Medicines, Access & Knowledge，簡稱 I-MAK）的創辦人及執行長。他曾擔任多個國際組織的顧問，包括歐洲專利局、世界衛生組織及 Unitaid，並在美國國會就專利及不可持續的藥品價格作證。
Rohit Malpani 是獨立顧問，曾擔任無國界醫生組織（Médecins Sans Frontières）可及性運動的政策主任。他曾擔任 Unitaid 的董事會成員、樂施會（Oxfam）的特別顧問，以及世界衛生組織的人權顧問。
